ALINIA

Drug Romark Laboratories, LC
Total Payments
$68,818
Transactions
3,223
Doctors
1,056
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2020 $66,193 3,222 1,055
2019 $2,625 1 1

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $66,166 3,220 96.1%
Unspecified $2,625 1 3.8%
Entertainment $25.53 1 0.0%
Gift $1.95 1 0.0%

Payments by Type

General
$66,193
3,222 transactions
Research
$2,625
1 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection Romark Laboratories, LC $2,625 1

Top Doctors Receiving Payments for ALINIA — Page 43

Doctor Specialty Location Total Records
, M.D Student in an Organized Health Care Education/Training Program Atlanta, GA $3.20 1
, M.D Family Medicine Atlanta, GA $3.05 1
, M.D Gastroenterology Chicago, IL $2.72 1
, M.D Gastroenterology Kingsport, TN $2.00 1
, M.D Gastroenterology Mckinney, TX $1.77 1
, MD Gastroenterology Quincy, MA $0.26 1

About ALINIA

ALINIA is a drug associated with $68,818 in payments to 1,056 healthcare providers, recorded across 3,223 transactions in the CMS Open Payments database. The primary manufacturer is Romark Laboratories, LC.

Payment data is available from 2019 to 2020. In 2020, $66,193 was paid across 3,222 transactions to 1,055 doctors.

The most common payment nature for ALINIA is "Food and Beverage" ($66,166, 96.1% of total).

ALINIA is associated with 1 research study, including "Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection" ($2,625).